Answers are grounded in this paper and cite their sources.
Guideline outlines standardized mass spectrometry proteomics workflows for cardiac tissue and primary cells, supporting reproducible discovery of therapeutic targets.
Mass spectrometry-based cardiac proteomics provides direct molecular insight into cardiac physiology and disease. While plasma proteomics has advanced biomarker discovery, the analysis of cardiac tissue is essential for mechanistic understanding and therapeutic target identification; however, proteomic investigation of cardiac tissue faces unique challenges, including limited sample availability, regional heterogeneity, variability in collection and processing, and inconsistent reporting practices that hinder reproducibility and data integration. Here, we provide a practical framework for designing and conducting mass spectrometry-based proteomic studies of cardiac tissue and primary cardiac cells. We outline best practices and key considerations for sample handling, experimental design, data acquisition, quality control and statistical analysis. This guideline aims to support cardiac researchers in generating robust and reproducible proteomics datasets that advance our understanding of cardiac biology in both physiological and pathological contexts.
No takes yet. Share an insight, caveat, or question.
Lundby et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: